US advertising campaign begins for alternative to sildenafilBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7413.468-e (Published 28 August 2003) Cite this as: BMJ 2003;327:468
- Deborah Josefson
The US Food and Drug Administration has just approved vardenafil, a new drug for erectile dysfunction. The drug, to be marketed as Levitra, is to be launched with a high profile advertising campaign using top US sports stars.
The FDA's approval was based on more than 50 trials involving over 5700 men that compared vardenafil with placebo. Men taking vardenafil were on average five times more likely to achieve an erection that sustained intercourse than men taking a placebo, the results of these studies showed. Vardenafil worked …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial